Growth Drivers Accelerating the US Bioprocess Technology Market at 16.8% CAGR
The US Bioprocess Technology Market represents a significant share of the global industry, driven by the country's strong biotechnology ecosystem, extensive pharmaceutical manufacturing capabilities, and substantial investments in biologics research and development. The presence of leading biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and world-class...
0 Kommentare
0 Anteile
510 Ansichten